About us

herantis_image_12New therapies for a better life

Millions of people all over the world suffer from diseases, for which there is no known treatment. At the same time, thousands of skilled scientists are working on early research projects, which might one day provide novel therapies for the people in need.

Herantis Pharma plc. is a specialty pharmaceutical company bridging the gap from bench to bedside, aiming to develop novel pharmaceutical products based on some of the leading scientific research in the world. Our focus is in indications of unmet clinical need such as Dry eye, Parkinson’s disease, and Secondary lymphedema, where we intend to develop selected drug candidates through late preclinical and early clinical stages to reach a clinical Proof-of-Concept.

Herantis’ shares are listed on NASDAQ OMX Helsinki First North Finland.

Board of Directors

Pekka Mattila Pekka Mattila is one of the founders of Finnzymes Group and served as its CEO for 25 years until its acquisition by Thermo Fisher Scientific in 2010.
Read More

Jonathan Knowles Previously President of group research at Roche, Professor Knowles was also a member of the Genentech Board for 12 years and of the Chugai Board for seven years.
Read More

Jim Phillips Jim Phillips holds a number of Non-executive directorships in Europe including Insense Ltd and Healthcare Brands International Ltd.
Read More

Aki Prihti One of the founding partners of Inveni Capital, a venture fund focused on life sciences, Aki Prihti has experience of Board positions in several Life Sciences growth companies.
Read More

Timo Veromaa Herantis board member since 2012, Dr. Veromaa has been the CEO and President of Biotie Therapies Corp. since 2005.
Read More

Frans Wuite Currently CEO and President of Oncos Therapeutics Ltd, Mr. Wuite has a long international career with a track record of successfully launching and growing pharmaceutical and biotech businesses.
Read More

Senior Team

Pekka Simula Chief Executive Officer
Read More

Sigrid Booms Director of Clinical Development
Read More

Burkhard Blank Chief Medical Officer
Read More

Jutta Poutanen Chief Pharmaceutical Officer
Read More

Henri J. Huttunen Chief Scientific Officer
Read More

Katarina Jääskeläinen Project Manager
Read More